Literature DB >> 9179208

A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography.

F Scopinaro1, O Schillaci, W Ussof, K Nordling, R Capoferro, G De Vincentis, R Danieli, M Ierardi, V Picardi, R Tavolaro, A C Colella.   

Abstract

In order to assess specificity and sensitivity of the prone scintimammography (PSM) in a large series with 99m-Tc MIBI, we performed a three-center study; 420 patients were studied; after mammography all the patients were submitted to PSM and biopsy and/or operation. PSM was considered positive if hot spot within the breast was observed. In palpable masses sensitivity was 0.98 and specificity 0.89, non palpable masses showed a sensitivity of 0.62 and a specificity of 0.91. When the cancers were stratified for T category the sensitivity was 0.28 in T1a 0.26 in the group of T1a carcinomas, 0.56 in T1b 0.95 in T1c and 0.97 T2 tumors. Physical factors such as attenuation. Compton scattering from chest, as well as biological factors have a role in breast tumor imaging. In the tumors smaller than 1 cm biological factors are probably involved too.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179208

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  [Functional and molecular imaging of breast tumors].

Authors:  K Pinker; P Brader; G Karanikas; K El-Rabadi; W Bogner; S Gruber; M Reisegger; S Trattnig; T H Helbich
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

2.  Dual-modality breast tomosynthesis.

Authors:  Mark B Williams; Patricia G Judy; Spencer Gunn; Stanislaw Majewski
Journal:  Radiology       Date:  2010-04       Impact factor: 11.105

3.  Molecular Imaging in Breast Cancer - Potential Future Aspects.

Authors:  Katja Pinker; Wolfgang Bogner; Stephan Gruber; Peter Brader; Siegfried Trattnig; Georgios Karanikas; Thomas H Helbich
Journal:  Breast Care (Basel)       Date:  2011-04-29       Impact factor: 2.860

4.  [Molecular breast imaging. An update].

Authors:  K Pinker; T H Helbich; H Magometschnigg; B Fueger; P Baltzer
Journal:  Radiologe       Date:  2014-03       Impact factor: 0.635

5.  Scintimammography as an adjunctive breast imaging technology: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2007-04-01

6.  Breast scintigraphy today: indications and limitations.

Authors:  Orazio Schillaci; John R Buscombe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-23       Impact factor: 9.236

Review 7.  The role of nuclear medicine in breast cancer detection: a focus on Technetium-99 Sestamibi scintimammography.

Authors:  Lina Romero; Iraj Khalkhali; Hernan I Vargas
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

8.  Diagnostic Performance of Breast-Specific Gamma Imaging (BSGI) for Breast Cancer: Usefulness of Dual-Phase Imaging with (99m)Tc-sestamibi.

Authors:  Ji Sun Park; Ah Young Lee; Kyung Pyo Jung; Su Jung Choi; Seok Mo Lee; Sang Kyun Bae
Journal:  Nucl Med Mol Imaging       Date:  2012-10-13

9.  Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.

Authors:  Vassilios J Papantoniou; Michael A Souvatzoglou; Varvara J Valotassiou; Androniki N Louvrou; Constantina Ambela; John Koutsikos; Dimitrios Lazaris; Julie K Christodoulidou; Maria G Sotiropoulou; Maria J Melissinou; Aris Perperoglou; Spyridon Tsiouris; Cherry J Zerva
Journal:  Breast Cancer Res       Date:  2003-12-11       Impact factor: 6.466

10.  99mTc-thymine scintigraphy may be a promising method in the diagnosis of breast cancer.

Authors:  Monica Pires Ribeiro; Sergio Augusto Lopes de Souza; Flavia Paiva Proença Lobo Lopes; Paulo Henrique Rosado-de-Castro; Lea Mirian Barbosa da Fonseca; Bianca Gutfilen
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.